Latus Bio Adds Biotech Veterans as Gene Therapies Enter Clinic
PHILADELPHIA, PA — Latus Bio added veteran biopharmaceutical executives Donald Hayden and Michael MacLean to its board as the Philadelphia biotechnology company moves into clinical development with gene therapies targeting …
Latus Bio Adds Biotech Veterans as Gene Therapies Enter Clinic Read More